American Well Corp stock (US03044L1052): Telehealth player navigates market headwinds after latest earnings update

American Well Corp recently reported quarterly results and continues to adjust its telehealth strategy in a challenging digital health market. What matters now for investors watching the US-listed stock?

American Well Corp, better known as Amwell, remains one of the better-known pure-play telehealth providers in the US market, even as investors reassess digital health valuations after the pandemic boom. The company has continued to update shareholders on its latest quarterly results and strategic priorities, while the stock reflects a market that is still trying to price long-term demand for virtual care and software platforms.

In its most recent reported quarter, Amwell highlighted ongoing progress in shifting its business mix toward a software-as-a-service platform model and virtual care enablement, while also acknowledging that health system budget pressures and macro uncertainty remain headwinds. Management reiterated its focus on tightening operating expenses and improving the path toward potential profitability, a message that has become standard across many digital health and software names. These dynamics frame how market participants are evaluating American Well Corp stock on US exchanges today.

As of: 09.06.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: AMWL
• Sector/industry: Digital health / telemedicine
• Headquarters/country: United States
• Core markets: US health systems, health plans and employers
• Key revenue drivers: Software platform fees, professional telehealth services and related technology
• Home exchange/listing venue: New York Stock Exchange (ticker: AMWL)
• Trading currency: USD

American Well Corp: core business model

American Well Corp operates as a digital health technology company focused on enabling virtual care delivery for health systems, health plans, employers and other stakeholders in the US healthcare ecosystem. The company is best known for its Amwell telehealth platform, which allows clinicians and patients to connect via video, chat and other digital tools to conduct remote consultations, manage ongoing conditions and support hybrid care models.

Over time, Amwell has positioned itself less as a pure telemedicine visit provider and more as a software and infrastructure partner for large health systems and payers. That means the company aims to provide the technology backbone, integration and workflow tools that allow hospitals and physician groups to deploy their own branded virtual care solutions. This approach can involve deep integration with electronic health record systems, patient portals and scheduling platforms, making the relationship more sticky but also longer to ramp.

In addition to software and platform fees, American Well Corp still generates revenue from professional clinical services and visit fees in certain arrangements. However, the strategic narrative emphasizes the move toward a higher proportion of recurring software revenue, which typically carries more attractive gross margins and aligns with how many US investors value health-tech and software companies. The mix between platform revenue and service revenue, and how it changes quarter to quarter, is an important lens for evaluating the company’s progress.

The business model also depends on maintaining and expanding a network of clinicians and provider organizations who are comfortable using digital tools. For large health systems, Amwell’s value proposition includes enabling virtual specialty care, on-demand urgent care, and remote monitoring programs that can help manage capacity constraints and respond to patient expectations for convenience. For health plans and employers, the pitch often centers on improving access, potentially lowering costs and offering a modern benefit experience.

Main revenue and product drivers for American Well Corp

The main revenue streams for American Well Corp can broadly be grouped into software and platform fees, professional services and implementation work, and revenue related to clinical telehealth services. In recent communications, management has generally emphasized the growth of recurring software and subscription revenue as a core strategic objective, as this component is seen as central to the long-term scalability of the business.

Software and platform fees are typically generated from multi-year contracts with health systems, health plans and other enterprise customers. These contracts can be structured with minimum commitments, tiered pricing based on usage, or enterprise license models. When the company signs a large health system or payer, implementation and configuration efforts may initially weigh on margins, but the revenue contribution can increase as usage ramps over time. Investors often pay close attention to metrics such as annual recurring revenue, net dollar retention and the number of large enterprise customers when they are reported.

Professional services and implementation work represent another important revenue driver, especially when the company deploys its platform across complex health system environments. This can include integration with electronic health records, custom workflows, training, change management and other forms of support. While this revenue may carry lower margins than software fees, it can be crucial for strengthening customer relationships and encouraging longer-term usage of the platform.

The clinical services side of the business, where Amwell facilitates or directly provides physician and clinician visits, also contributes to revenue. This segment saw a surge during the height of the COVID-19 pandemic, when many patients turned to telehealth to avoid in-person visits. Since then, utilization has normalized, and the company has sought to position clinical services more as a complement to its software business. Investor attention has therefore shifted toward the stability and scalability of software-generated revenue, rather than short-term spikes in visit volume.

Across these segments, American Well Corp continues to invest in product development. This includes enhancing workflow tools for clinicians, improving patient-facing user interfaces, and expanding capabilities such as remote monitoring, triage and automation. The company has also discussed the potential of digital tools to help health systems manage labor shortages and capacity constraints by enabling clinicians to care for patients across locations more flexibly. For many US investors, the question is how quickly such innovations can translate into sustained revenue growth and improving margins.

Industry trends and competitive position

The broader telehealth and digital health industry has undergone a pronounced transition since the pandemic-driven peak in virtual care usage. After a surge in demand during 2020 and 2021, many providers and payers have reported a stabilization in telehealth volumes at levels higher than before the pandemic but lower than peak. This has forced companies like American Well Corp to adjust growth expectations and focus more on durable enterprise relationships and integrated care models rather than short-term spikes.

Competition is intense, with rivals ranging from other telehealth specialists to large electronic health record providers and diversified technology companies that are expanding into healthcare. In this environment, Amwell seeks differentiation by offering a comprehensive virtual care platform designed specifically for health systems and payers, aiming to integrate deeply with existing clinical workflows. Strategic partnerships and technical integration capabilities are therefore key elements of its competitive positioning.

Regulatory and reimbursement trends also play a decisive role. In the US, telehealth reimbursement flexibilities introduced during the pandemic were gradually revisited and, in some cases, extended, but long-term policy remains an area of active discussion. For American Well Corp, stable reimbursement frameworks and supportive regulations can underpin customer investment in virtual care infrastructure. Conversely, uncertainty can affect decision-making timelines for health systems considering large platform deployments.

The digital health funding environment has cooled compared with the 2020–2021 period, with investors paying closer attention to profitability paths and sustainable unit economics. This shift affects telehealth platforms that are still working toward scale. American Well Corp has therefore joined a broader cohort of health-tech companies seeking cost discipline, restructuring programs and careful capital allocation. For investors, progress on operating leverage and cash burn reduction has become as important as top-line growth.

Why American Well Corp matters for US investors

For US investors, American Well Corp represents exposure to structural trends in healthcare digitization and virtual care, albeit with the volatility typical of growth-oriented health-tech names. The company’s primary listing on the New York Stock Exchange, under the ticker AMWL, means it trades during regular US market hours and is influenced by broader movements in the US equity and health-tech sectors.

The potential addressable market for virtual care infrastructure in the US remains sizable, given the scale of the healthcare system, ongoing clinician shortages and patient demand for convenient access. If health systems and payers continue to embed digital tools into routine care, companies like Amwell could benefit from longer-term contracts and recurring revenue streams. At the same time, the path to capturing that opportunity involves execution risk, competition and evolving reimbursement rules.

US investors often compare American Well Corp to other telehealth and digital health competitors when assessing relative growth, profitability trajectories and valuation multiples. Factors such as revenue mix, customer retention, contract wins and spending discipline are frequently cited in earnings discussions and market commentary. The stock’s performance can also react to macroeconomic indicators, changes in interest rate expectations and sentiment toward unprofitable or early-stage growth companies more broadly.

Conclusion

American Well Corp stands at the intersection of healthcare and technology in the US, with a business model that combines enterprise software, services and virtual care capabilities. The company has communicated a shift toward a more software-centric revenue mix and a focus on operating discipline after the telehealth surge of recent years. For investors, the key questions revolve around the sustainability of demand from health systems and payers, the company’s ability to differentiate in a competitive landscape, and the timeline for translating growth into improved profitability metrics. As with many digital health stocks, American Well Corp’s share price can be sensitive to earnings updates, guidance commentary and broader shifts in risk appetite within the US equity market.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.